InQuery vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
SF YC W24 AI medical record review for health insurance prior auth and claims; $3.1M from General Catalyst/DRW/YC deploying AI agents that process clinical documentation for coverage decisions competing with Cohere Health.
About
InQuery is a San Francisco-based AI healthcare platform — backed by Y Combinator (W24) with $3.1 million in total funding from Y Combinator, General Catalyst, Amino Capital, and DRW Venture Capital — providing health insurance companies and managed care organizations with AI agents that autonomously review medical records, analyze clinical documentation, and process prior authorization and claims decisions at a speed and scale that human reviewers cannot match. Founded in 2023, InQuery applies large language models trained on clinical documentation to the insurance review workflows that currently require teams of nurses and physician advisors to manually read through hundreds of pages of medical records per case.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.